Stoke Therapeutics, Inc (STOK) insider trading
Every open-market stock purchase and sale by Stoke Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Barry Ticho (C-suite exec) and 2 others sold $1.3M in the last 90 days.
- Last insider buy: Apple Tree Partners IV L.P. (10% owner), $14.6M, 5 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $11M (33 sales). Last close $24.80 on Sep 25, 2026.
Recent STOK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | Alexander Cumbo (Insider) | Bought (not open market) | — |
| Sep 1, 2026 | Barry Ticho (C-suite exec) | Sold | $120K |
| Sep 1, 2026 | Barry Ticho (C-suite exec) | Sold | $49.7K |
| Aug 18, 2026 | Edward M. Kaye MD (Insider) | Sold | $382K |
| Aug 18, 2026 | Barry Ticho (C-suite exec) | Sold | $145K |
| Aug 18, 2026 | Jonathan Allan (General Counsel) | Sold | $86.9K |
| Aug 18, 2026 | Edward M. Kaye MD (Insider) | Sold | $20.7K |
| Aug 18, 2026 | Barry Ticho (C-suite exec) | Sold | $7.9K |
| Aug 18, 2026 | Jonathan Allan (General Counsel) | Sold | $4.7K |
| Aug 14, 2026 | Jonathan Allan (General Counsel) | Bought (not open market) | — |
| Aug 14, 2026 | Barry Ticho (C-suite exec) | Bought (not open market) | — |
| Aug 14, 2026 | Edward M. Kaye MD (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Barry Ticho (C-suite exec) | Sold | $171K |
| Aug 3, 2026 | Barry Ticho (C-suite exec) | Sold | $37.4K |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 16, 2026 | Seth Loring Harrison (Insider) | Bought (not open market) | — |
| Jul 15, 2026 | Thomas McCauley (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Barry Ticho (C-suite exec) | Sold | $219K |
| Jul 1, 2026 | Barry Ticho (C-suite exec) | Sold | $16.6K |
Who's trading STOK
- Alexander Cumbo, Insider: other filings, last Sep 23, 2026
- Barry Ticho, C-suite exec: sold $1.9M (29 sales), last Sep 1, 2026
- Edward M. Kaye MD, Insider: sold $3.2M (16 sales), last Aug 18, 2026
- Jonathan Allan, General Counsel: sold $1.6M (22 sales), last Aug 18, 2026
- Seth Loring Harrison, Insider: other filings, last Jul 16, 2026
- Thomas McCauley, C-suite exec: other filings, last Jul 15, 2026
- Adrian R. Krainer, Insider: sold $3.9M (5 sales), last Jun 3, 2026
- Jennifer Burstein, Insider: other filings, last Jun 3, 2026
- Julie Smith, Insider: other filings, last Jun 3, 2026
- Arthur A Levin, Insider: sold $22.3K (1 sale), last Jun 3, 2026
- Arthur Tzianabos, Chair: sold $174K (1 sale), last Jun 3, 2026
- Clare Kahn, Insider: other filings, last Apr 3, 2026
- Thomas Leggett, CFO: sold $147K (5 sales), last Mar 18, 2026
- Jason Hoitt, C-suite exec: sold $119K (5 sales), last Mar 18, 2026
- Ian F Smith, CEO: other filings, last Feb 17, 2026
Get free alerts when an insider at Stoke Therapeutics, Inc files a new trade →